[1. Firkin BG, Whitwort JA. Dictionary of medical eponyms. Basel: Roche; 1996.]Search in Google Scholar
[2. Kocić R, Radenković S. Bolesti štitne žlezde [Thyroid disorders]. U: Ilić S, ur. Interna medicina [In: Ilić S, ed. Internal Medicine]. Niš: Medicinski fakultet Niš; 2009. p. 307-19. (Serbian).]Search in Google Scholar
[3. Micić D. Oboljenja štitne žlezde [Thyroid disorders]. U: Klinički centar Srbije, ur. Enciklopedija zdravlja [In Clinical center of Serbia, ed. Encyclopedia of health]. Beograd: Press; 2012. Volume 26.p. 1-4. (Serbian).]Search in Google Scholar
[4. Braun-Falco O, Petzold D. E.M.O. syndrome. Exophthalmoscircumscribed pretibial myxedema-hypertrophic osteoarthropathy. Münchn Med Wochenschr 1967;79:1523-9.]Search in Google Scholar
[5. Georgala S, Katoulis AC, Georgala C, Katoulis EC, Hatziolou E, Stavrianeas NG. Pretibial myxedema as the initial manifestation of Graves’ disease. J Eur Acad Dermatol Venereol 2002;16: 380-3.10.1046/j.1468-3083.2002.00567.x12224697]Search in Google Scholar
[6. Anderson CK, Miller F. Triad of exophthalmos, pretibial myxedema, and acropachy in a patient with Graves’ disease. J Am Acad Dermatol 2003; 48 (6): 970-2.10.1067/mjd.2003.32312789197]Search in Google Scholar
[7. Castineiras I, Del Pozo J, Robles O. Euthyroid nodular pretibial mucinosis: palliative treatment with carbon dioxide laser. Dermatol Surg 2009;35: 719-21.10.1111/j.1524-4725.2009.01115.x19400889]Search in Google Scholar
[8. Şenel E, Güleç AT. Euthyroid pretibial myxedema and EMO syndrome. Acta Dermatovenerol Alp Panonica Adriat 2009;18(1):21-3.]Search in Google Scholar
[9. Fatourechi V. Pretibial myxedema. Pathophysiology and treatment options. Am J Clin Dermatol 2005;6(5):295-309.]Search in Google Scholar
[10. Cannavo SP, Borgia F, Vaccaro M, Guameri F, Magliolo E, Guarneri B. Pretibial myxedema associated with Hashimoto’s thyroiditis. J Eur Acad Dermatol Venereol 2002;16:625-7.10.1046/j.1468-3083.2002.00532.x12482050]Search in Google Scholar
[11. Bahn RS. Pathophysiology of Graves’ ophthalmopathy: The cycle of Disease. J Clin Endocrinol Metab 2003:88(5):1939-45.10.1210/jc.2002-03001012727937]Search in Google Scholar
[12. Fatourechi V, Pajouhi M, Fransway A. Dermopathy of Graves’ disease (pretibial myxedema). Review of 150 cases. Medicine 1994;73:1-7.10.1097/00005792-199401000-000018309359]Search in Google Scholar
[13. Ludgate M, Baker G. Unlocking the immunological mechanisms of orbital inflammation in thyroid eye disease. Clin Exp Immunol 2002;127:193-8.10.1046/j.1365-2249.2002.01792.x190633811876739]Search in Google Scholar
[14. Heufelder AE, Weetman AP, Ludgate M, Bahn RS. Pathogenesis of Graves’ ophthalmopathy. In: Prummel MF, Wirsinga WM, Mourits MP, eds. Recent developments in Graves’ ophthalmopathy. Dordrecht: Kluwer Academic Publishers; 2000. p. 15-37.10.1007/978-1-4615-4647-4_2]Search in Google Scholar
[15. Daumerie C, Ludgate M, Costagliola S, Many MC. Evidence for thyrotropin receptor immunoreactivity in pretibial connective tissue from patients with thyroid-associated dermopathy. EurEndocrinol 2002;:146:35-8.10.1530/eje.0.146003511751064]Search in Google Scholar
[16. Wolf K, Johnson RA, Suurmond D. Fitzpatrick’ color atlas and synopsis of clinical dematology. 5th ed. New York: McGraw- Hill Professional; 2005. p 443-4.]Search in Google Scholar
[17. Jolles S, Hughes J. Use of IGIV in the treatment of atopic dermatitis, urticaria, scleromyxedema, pyoderma gangrenosum, psoriasis and pretibial myxedema. Int Immunopharmacol 2006;6:579-91.10.1016/j.intimp.2005.11.01716504920]Search in Google Scholar
[18. Schwartz KM, Fatourechi V, Ahmed DDF, Pond GR. Dermopathy of Graves’ disease (Pretibial myxedema): long-term outcome. J Clin Endocrinol Metab 2002;87(29):438-46.]Search in Google Scholar
[19. Cho S, Choi J-H, Sung K-J, Moon KC, Koh J-K. Graves’s disease presenting as elephantiasic pretibial myxedema and nodules of the hands. Int J Dermatol 2001;40:276-7.10.1046/j.1365-4362.2001.01108.x11454085]Search in Google Scholar
[20. Schwartz KM, Ahmed DDF, Ahmed I, Fatourechi V. Development of localized myxedema in skin graft. Int J Dermatol 2002;41:401-3.10.1046/j.1365-4362.2002.01535_3.x12121553]Search in Google Scholar
[21. Fatourechi V, Bartley GB, Eghbali-Fatourechi GZ, Powell CC, Ahmed DD, Garrity JA. Graves’ dermopathy and acropachy are markers of sever Graves’s ophthalmopathy. Thyroid 2003;13(12):1141-4.10.1089/1050725036073154114751035]Search in Google Scholar
[22. Mack WP, Stasior GO, Cao JH, Stasior OG, Smith TJ. The effect of cigarette smoke constituents on the expression of HLADR in orbital fibroblasts derived from patients with Graves’ ophthalmopathy. Ophthal Plast Reconstr Surg l999;15(4):260-71.10.1097/00002341-199907000-0000710432522]Search in Google Scholar
[23. Weetman AP. Graves’ disease. N Engl J Med 2000;26:1236-48.10.1056/NEJM20001026343170711071676]Search in Google Scholar
[24. Pineda AMM, Tianco EAV, Tan JB, Casintahan FA, Beloso MB. Oral pentoxifylline and topical clobetasol propionate ointment in the treatment of pretibial myxedema, with concomitant improvement of Graves’ ophthalmopathy. J Eur Acad Dermatol Venereol 2007;21:1441-2.10.1111/j.1468-3083.2007.02259.x17958873]Search in Google Scholar
[25. Susser WS, Heermans AG, Chapman MS, Baughman RD. Elephantiasic pretibial myxedema: A novel treatment for an uncommon disorder. J Am Acad Dermatol 2002;46:723-6.10.1067/mjd.2002.11965512004314]Search in Google Scholar
[26. Terheyden P, Kahaly GJ, Zillikens D, Brücher E-B. Lack of rseponse of elephantiasic pretibial myxoedema to treatment with high-dose intravenous immunoglobulins. Clin Exp Dermatol 2003;28:224-6.10.1046/j.1365-2230.2003.01232_3.x12653721]Search in Google Scholar
[27. Felton J, Derrick EK, Price ML. Successful combine surgical and octreotide treatment of severe pretibial myxoedema reviewed after 9 years. Br J Dermatol 2003;148:825-6.10.1046/j.1365-2133.2003.05236.x12752151]Search in Google Scholar
[28. Shinohara M, Hamasaky Y, Katayama J. Refractory pretibial myxedema with response to intralesional insulin-like growth factor 1 antagonist (octreotide): downregulation of hyaluronic acid production by the lesional fibroblasts. Br J Dermatol 2000;143:1083-6. 10.1046/j.1365-2133.2000.03850.x11069527]Search in Google Scholar